These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 27703008)
1. The Role of Folate Transport in Antifolate Drug Action in Trypanosoma brucei. Dewar S; Sienkiewicz N; Ong HB; Wall RJ; Horn D; Fairlamb AH J Biol Chem; 2016 Nov; 291(47):24768-24778. PubMed ID: 27703008 [TBL] [Abstract][Full Text] [Related]
2. The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis. Assaraf YG Drug Resist Updat; 2006; 9(4-5):227-46. PubMed ID: 17092765 [TBL] [Abstract][Full Text] [Related]
3. Genome-wide RNAi screens in bloodstream form trypanosomes identify drug transporters. Schumann Burkard G; Jutzi P; Roditi I Mol Biochem Parasitol; 2011 Jan; 175(1):91-4. PubMed ID: 20851719 [TBL] [Abstract][Full Text] [Related]
4. The molecular basis of folate salvage in Plasmodium falciparum: characterization of two folate transporters. Salcedo-Sora JE; Ochong E; Beveridge S; Johnson D; Nzila A; Biagini GA; Stocks PA; O'Neill PM; Krishna S; Bray PG; Ward SA J Biol Chem; 2011 Dec; 286(52):44659-68. PubMed ID: 21998306 [TBL] [Abstract][Full Text] [Related]
5. Regulation of carrier-mediated transport of folates and antifolates in methotrexate-sensitive and-resistant leukemia cells. Jansen G; Mauritz RM; Assaraf YG; Sprecher H; Drori S; Kathmann I; Westerhof GR; Priest DG; Bunni M; Pinedo HM; Schornagel JH; Peters GJ Adv Enzyme Regul; 1997; 37():59-76. PubMed ID: 9381986 [TBL] [Abstract][Full Text] [Related]
6. Variable expression of RFC1 in human leukemia cell lines resistant to antifolates. Kobayashi H; Takemura Y; Ohnuma T Cancer Lett; 1998 Feb; 124(2):135-42. PubMed ID: 9500202 [TBL] [Abstract][Full Text] [Related]
7. Regulators of Trypanosoma brucei cell cycle progression and differentiation identified using a kinome-wide RNAi screen. Jones NG; Thomas EB; Brown E; Dickens NJ; Hammarton TC; Mottram JC PLoS Pathog; 2014 Jan; 10(1):e1003886. PubMed ID: 24453978 [TBL] [Abstract][Full Text] [Related]
9. Folate transport and the modulation of antifolate sensitivity in a methotrexate-resistant human breast cancer cell line. Dixon KH; Trepel JB; Eng SC; Cowan KH Cancer Commun; 1991; 3(12):357-65. PubMed ID: 16296001 [TBL] [Abstract][Full Text] [Related]
10. Clustering of mutations in the first transmembrane domain of the human reduced folate carrier in GW1843U89-resistant leukemia cells with impaired antifolate transport and augmented folate uptake. Drori S; Jansen G; Mauritz R; Peters GJ; Assaraf YG J Biol Chem; 2000 Oct; 275(40):30855-63. PubMed ID: 10899164 [TBL] [Abstract][Full Text] [Related]
11. Multiple mechanisms of resistance to methotrexate and novel antifolates in human CCRF-CEM leukemia cells and their implications for folate homeostasis. Mauritz R; Peters GJ; Priest DG; Assaraf YG; Drori S; Kathmann I; Noordhuis P; Bunni MA; Rosowsky A; Schornagel JH; Pinedo HM; Jansen G Biochem Pharmacol; 2002 Jan; 63(2):105-15. PubMed ID: 11841783 [TBL] [Abstract][Full Text] [Related]
12. Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines. Rothem L; Ifergan I; Kaufman Y; Priest DG; Jansen G; Assaraf YG Biochem J; 2002 Nov; 367(Pt 3):741-50. PubMed ID: 12139489 [TBL] [Abstract][Full Text] [Related]
13. The antifolates: evolution, new agents in the clinic, and how targeting delivery via specific membrane transporters is driving the development of a next generation of folate analogs. Goldman ID; Chattopadhyay S; Zhao R; Moran R Curr Opin Investig Drugs; 2010 Dec; 11(12):1409-23. PubMed ID: 21154123 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in the understanding of the mechanism of membrane transport of folates and antifolates. Sierra EE; Goldman ID Semin Oncol; 1999 Apr; 26(2 Suppl 6):11-23. PubMed ID: 10598550 [TBL] [Abstract][Full Text] [Related]
15. An RNAi screen of the RRM-domain proteins of Trypanosoma brucei. Wurst M; Robles A; Po J; Luu VD; Brems S; Marentije M; Stoitsova S; Quijada L; Hoheisel J; Stewart M; Hartmann C; Clayton C Mol Biochem Parasitol; 2009 Jan; 163(1):61-5. PubMed ID: 18840477 [TBL] [Abstract][Full Text] [Related]
16. Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6. Baker N; Alsford S; Horn D Mol Biochem Parasitol; 2011 Mar; 176(1):55-7. PubMed ID: 21093499 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of the Leishmania tarentolae pterin transporter (BT1) and reductase (PTR1) genes leads to viable parasites with changes in folate metabolism and hypersensitivity to the antifolate methotrexate. El Fadili A; Kündig C; Roy G; Ouellette M J Biol Chem; 2004 Apr; 279(18):18575-82. PubMed ID: 14981076 [TBL] [Abstract][Full Text] [Related]
18. A structurally altered human reduced folate carrier with increased folic acid transport mediates a novel mechanism of antifolate resistance. Jansen G; Mauritz R; Drori S; Sprecher H; Kathmann I; Bunni M; Priest DG; Noordhuis P; Schornagel JH; Pinedo HM; Peters GJ; Assaraf YG J Biol Chem; 1998 Nov; 273(46):30189-98. PubMed ID: 9804775 [TBL] [Abstract][Full Text] [Related]
19. Effects of folate receptor expression following stable transfection into wild type and methotrexate transport-deficient ZR-75-1 human breast cancer cells. Dixon KH; Mulligan T; Chung KN; Elwood PC; Cowan KH J Biol Chem; 1992 Nov; 267(33):24140-7. PubMed ID: 1429743 [TBL] [Abstract][Full Text] [Related]